Clinical Trial Update: ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT) [Phase 2]

View source ↗

Summary

Phase 2 trial for ATI-502 topical solution in alopecia areata, alopecia universalis, and alopecia totalis was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata
• Alopecia Totalis
• Alopecia Universalis

Drugs mentioned

• ATI-502 (unknown)

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Alopecia Areata, Alopecia Universalis | Phase 2 | Status: TERMINATED | Results posted: 2020-09-17